Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal
1 other identifier
interventional
8
1 country
1
Brief Summary
This research study is evaluating suitability of a delayed magnetic resonance imaging (MRI) in management of spine tumors. Currently the standard of care is obtaining an MRI scan in the early postoperative period (within 72 hours after surgery). The purpose of this study is to see if delayed MRI (2 to 3 weeks after surgery) is similar in quality to the earlier MRI. In this study patients will undergo 2 MRIs after the surgery instead of one MRI. Patients will have one MRI about 3 days after the surgery and one MRI about 2-3 weeks after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2016
CompletedFirst Posted
Study publicly available on registry
June 3, 2016
CompletedStudy Start
First participant enrolled
August 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2020
CompletedMay 14, 2024
May 1, 2024
4.3 years
May 31, 2016
May 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients which have the same clinical decision from the immediate postoperative MRI and later imaging
Assess if Magnetic Resonance Imaging (MRI) at 2 to 3 weeks after surgery (aka: later imaging) leads to the same clinical decisions and has the same probability of being chosen by a physician for guiding the subsequent management of the patient, compared with immediately postoperative MRI (within 72 hours, aka: early imaging).
Up to 3 weeks after surgery
Secondary Outcomes (3)
Change in tumor volume between immediate and later postoperative MRI
Up to 3 weeks after surgery
Difference in level of discomfort as measured by a visual analog scale between postoperative MRIs
Up to 3 weeks after surgery
Progression of tumor using RECIST Criteria
Up to 3 weeks after surgery
Study Arms (1)
Postoperative Magnetic Resonance Imaging
EXPERIMENTALThree MRIs will be performed. One at baseline, one within 72 hours postoperative, and one 2-3 weeks postoperative.
Interventions
The routine spine MRI protocol will be utilized, which includes the following sequences: haste localizer, sagittal T1, T2, and short-T1 Inversion Recovery (STIR), axial T2 for lumbar spine or axial gradient echo for cervical and thoracic spine, axial T1, post contrast sagittal and axial T1. All scans will be obtained using a 1.5 Tesla magnet.
Eligibility Criteria
You may qualify if:
- Metastatic or primary malignant tumor involving spinal column, with or without extension into the epidural space
- Operated for debulking, decompression or separation surgery;
- A magnetic resonance imaging (MRI) scan performed within 72 hours after surgery is needed;
- Image quality acceptable for comparison with later MRI as read by a neuroradiologist;
- Karnofsky score of 60 or higher;
- Able to consent for the study.
You may not qualify if:
- Any patient who previously underwent spinal surgery at these levels will be excluded to eliminate late postoperative changes.
- Intradural extension of the tumor.
- Patients, whose MRI at post operative 48-72 hours are not readable due to artifacts or disease process shall not be included in the study.
- Patient not able to tolerate MRI scan due to claustrophobia or severe pain or allergic reaction to contrast.
- Patients with an estimated Glomerular Filtration Rate (eGFR) \< or = to 30 will be excluded to avoid issues related to contrast administration in such patients. This Glomerular Filtration Rate (GFR) threshold cutoff level is chosen per institutional policy, because below that level other measures would be required (hydration or no contrast administration). In order to keep the imaging information as uniform as possible in such a small study group, patients with a low GFR will not be enrolled in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lilyana Angelov, MD
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2016
First Posted
June 3, 2016
Study Start
August 31, 2016
Primary Completion
December 17, 2020
Study Completion
December 17, 2020
Last Updated
May 14, 2024
Record last verified: 2024-05